Communication Issues in Patient and Provider Discussions of Immunotherapy
Launched by EMORY UNIVERSITY · May 16, 2023
Trial Information
Current as of July 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how patients and healthcare providers talk about immunotherapy, a type of cancer treatment that helps the body's immune system fight cancer. The study aims to find out where patients learn about immunotherapy, what they understand about it, and how doctors explain it. Additionally, the trial will look at how educational videos can help patients better understand this treatment option.
If you're a patient receiving care at the Winship Cancer Institute or if you are a healthcare provider involved in discussions about immunotherapy, you may be eligible to participate. Participants can expect to share their experiences and thoughts on immunotherapy discussions, and they'll also have the chance to watch educational videos that could enhance their understanding of the treatment. This study is currently recruiting participants of all ages and genders who have an interest in immunotherapy for cancer.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • AIMS 1-3: All patients and providers who may have a discussion about immunotherapy at the Winship Cancer Institute
- • AIM 4: Any cancer patient
About Emory University
Emory University, a leading research institution located in Atlanta, Georgia, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, Emory harnesses the expertise of its renowned faculty and state-of-the-art facilities to conduct cutting-edge research across various fields, including oncology, neurology, and infectious diseases. The university's commitment to ethical research practices and patient safety ensures that all clinical trials are designed to generate valuable data that can lead to significant therapeutic advancements. By fostering partnerships with local hospitals and community organizations, Emory strives to translate research findings into real-world applications, ultimately enhancing health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Atlanta, Georgia, United States
Decatur, Georgia, United States
Patients applied
Trial Officials
Rebecca Pentz, PhD
Principal Investigator
Emory University Hospital/Winship Cancer Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported